THEON's New Investment in Exosens SA
THEON International Plc (THEON) has made a significant move in the investment landscape by agreeing to purchase a 9.8% stake in Exosens SA. This acquisition, valued at €268.7 million, equates to a remarkable price of €54.0 per share. The deal reflects THEON's commitment to expanding its portfolio and enhancing its technological capabilities.
About Exosens SA
Exosens SA is a notable player in the field of electro-optical technologies. The company's expertise lies in light amplification, detection, and imaging systems, which are essential in various industries, including defense and security. This acquisition positions THEON as the second largest shareholder in Exosens, following the Groupe HLD's significant equity stake.
Details of the Transaction
The completion of this transaction is contingent on regulatory approvals across select countries and is anticipated to finalize in early Q1 2026. To facilitate this purchase, UBS Europe SE and Citibank Europe PLC have been enlisted to provide a bridge financing arrangement. This financial strategy aims to ensure a robust and adaptable capital structure for THEON moving forward.
Strengthening Partnerships
Christian Hadjiminas, THEON's Founder and CEO, expressed enthusiasm regarding the acquisition, emphasizing the long-term collaboration between THEON and Exosens. He noted how both companies have celebrated key contracts across Europe and the Middle East, underscoring a strong foundation of mutual success. The continued partnership will be governed under existing contractual arrangements, ensuring that both parties can leverage their synergies to achieve greater innovations.
Expert Insight and Advisory
In connection with this pivotal transaction, UBS Europe SE served as the sole financial advisor for THEON, while Clifford Chance provided necessary legal counsel. Their combined expertise will be crucial in navigating the complexities surrounding this major investment.
About THEON Group
Founded in 1997, THEON Group specializes in developing cutting-edge night vision and thermal imaging systems for defense and security applications. With a strong global presence, the company operates from various subsidiaries and production facilities strategically located around the world. With over 220,000 systems in service among armed and special forces in 71 countries—including 26 NATO allies—THEON's influence and reputation have soared. The company has been actively involved in enhancing defense technologies, showcasing its commitment to safeguarding security across regions.
Frequently Asked Questions
What does the acquisition of Exosens mean for THEON?
The acquisition enables THEON to strengthen its position in the advanced electro-optical technologies sector and enhances its offerings in defense and security.
How will this acquisition impact existing partnerships?
This acquisition is expected to bolster existing partnerships, particularly with Exosens, as both companies aim to leverage their strengths for mutual growth.
What is the financial structure behind the acquisition?
The financial structure includes bridge financing provided by UBS Europe SE and Citibank Europe PLC, which is intended to be refinanced through a mix of debt and newly issued equity.
When is the expected closing date for this transaction?
The closing date is expected to be in early Q1 2026, subject to regulatory approvals.
Who can I contact for more information about THEON?
For inquiries, you can reach out to Investor Relations—Nikos Malesiotis—at +30 210 6772290 or via email at ir@theon.com.
